A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study

References

• Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev 2015;24:1–16.
   PubMedGoogle Scholar
• Hansell DM, Goldin JG, King TE Jr, Lynch DA, Richeldi L, Wells AU. CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner society. Lancet Respir Med 2015;3:483–96.
   PubMed Web of Science ®Google Scholar
• Esposito AJ, Chu SG, Madan R, Doyle TJ, Dellaripa PF. Thoracic manifestations of rheumatoid arthritis. Clin Chest Med 2019;40:545–60.
   PubMed Web of Science ®Google Scholar
• Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev 2021;30:210011.
   PubMed Web of Science ®Google Scholar
• Ottaviani S, Khaleche S, Borie R, Debray MP, Dieude P, Crestani B. Rheumatological evaluation of patients with interstitial lung disease. Scand J Rheumatol 2022;51:34–41.
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 2017;76:1700–6.
   PubMed Web of Science ®Google Scholar
• Sparks JA, Jin Y, Cho SK, Vine S, Desai R, Doyle TJ, et al. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford) 2021;60:3689–98.
   PubMed Web of Science ®Google Scholar
• Duarte AC, Porter JC, Leandro MJ. The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment. Rheumatology (Oxford) 2019;58:2031–8.
   PubMed Web of Science ®Google Scholar
• Samhouri BF, Vassallo R, Achenbach SJ, Kronzer VL, Davis JM 3rd, Myasoedova E, et al. The incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a population-based cohort. Arthritis Care Res 2022;74:2042–9.
   Web of Science ®Google Scholar
• Bargagli E, Bellisai F, Mazzei MA, Conticini E, Alderighi L, Cameli P, et al. Interstitial lung disease associated with psoriatic arthritis: a new disease entity? Int Emerg Med 2021;16:229–31.
   PubMed Web of Science ®Google Scholar
• Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN. Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol 2015;34:745–53.
   PubMed Web of Science ®Google Scholar
• Meltzer HM, Jensen TK, Majek O, Moshammer H, Wennberg M, Akesson A, et al. Enhancing human biomonitoring studies through linkage to administrative registers-status in Europe. Int J Environ Res Public Health 2022;19:5678.
   PubMed Web of Science ®Google Scholar
• Chatzidionysiou K, Delcoigne B, Frisell T, Hetland ML, Glintborg B, Dreyer L, et al. How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers. RMD Open 2020;6:e001363.
   PubMed Web of Science ®Google Scholar
• Kvien TK, Heiberg MS, Lie E, Kaufmann C, Mikkelsen K, Nordvag BY, et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005;23:S188–94.
   PubMed Web of Science ®Google Scholar
• Olsen IC, Haavardsholm EA, Moholt E, Kvien TK, Lie E. NOR-DMARD data management: implementation of data capture from electronic health records. Clin Exp Rheumatol 2014;32:S-158–62.
   Web of Science ®Google Scholar
• World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th revision 2019. Available from: https://icd.who.int/browse10/2019/en.
   Google Scholar
• Hoffmann-Vold AM, Aalokken TM, Lund MB, Garen T, Midtvedt O, Brunborg C, et al. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol 2015;67:2205–12.
   PubMed Web of Science ®Google Scholar
• Henry TS, Little BP, Veeraraghavan S, Bhalla S, Elicker BM. The spectrum of interstitial lung disease in connective tissue disease. J Thorac Imaging 2016;31:65–77.
   PubMed Web of Science ®Google Scholar
• Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733–48.
   PubMed Web of Science ®Google Scholar
• Cho SK, Doyle TJ, Lee H, Jin Y, Tong AY, Ortiz AJS, et al. Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis. Semin Arthritis Rheum 2020;50:592–7.
   PubMed Web of Science ®Google Scholar
• Herrinton LJ, Harrold LR, Liu L, Raebel MA, Taharka A, Winthrop KL, et al. Association between anti-TNF-alpha therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf 2013;22:394–402.
   PubMed Web of Science ®Google Scholar
• England BR, Roul P, Mahajan TD, Singh N, Yu F, Sayles H, et al. Performance of administrative algorithms to identify interstitial lung disease in rheumatoid arthritis. Arthritis Care Res 2020;72:1392–403.
   Web of Science ®Google Scholar
• Meehan M, Shah A, Lobo J, Oates J, Clinton C, Annapureddy N, et al. Validation of an algorithm to identify incident interstitial lung disease in patients with rheumatoid arthritis. Arthritis Res Ther 2022;24:2.
   PubMed Web of Science ®Google Scholar
• Fragoulis GE, Conway R, Nikiphorou E. Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature. Rheumatology (Oxford) 2019;58:1900–6.
   PubMed Web of Science ®Google Scholar